...
首页> 外文期刊>Analytical Biochemistry: An International Journal of Analytical and Preparative Methods >Monitoring G protein-coupled receptor activation using an adenovirus-based b-arrestin bimolecular fluorescence complementation assay
【24h】

Monitoring G protein-coupled receptor activation using an adenovirus-based b-arrestin bimolecular fluorescence complementation assay

机译:使用基于腺病毒的b-arrestin双分子荧光互补测定法监测G蛋白偶联受体的活化

获取原文
获取原文并翻译 | 示例
           

摘要

G protein-coupled receptors (GPCRs) are the largest family of cell-surface receptors and are involved in a variety of pathological conditions including cancer and cardiovascular, metabolic, neurological, and autoimmune diseases. GPCRs are being intensively investigated as targets for therapeutic intervention, and the b-arrestin recruitment assay has become a popular tool for analyzing GPCR activation. Here, we report a high-throughput method for cloning GPCR cDNAs into adenoviral bimolecular fluorescence complementation (BiFC) vectors and performing the b-arrestin BiFC assay in cells transduced with recombinant adenoviruses. An analysis of the activation of somatostatin receptor 2 (SSTR2) with the adenovirus-based b-arrestin BiFC assay showed that the assay is suitable for quantifying SSTR2 activation in response to specific agonists or antagonists. Furthermore, the adenovirus-based b-arrestin BiFC assay was able to detect the activation of a broad range of GPCRs. Collectively, our data indicate that the adenovirus-based b-arrestin BiFC assay can serve as a simple and universal platform for studying GPCR activation and thus will be useful for high-throughput screening of drugs that target GPCRs.
机译:G蛋白偶联受体(GPCR)是最大的细胞表面受体家族,涉及多种病理状况,包括癌症和心血管疾病,代谢,神经疾病和自身免疫性疾病。 GPCR被作为治疗干预的目标进行了深入研究,并且b-arrestin募集试验已成为分析GPCR激活的流行工具。在这里,我们报告了一种高通量方法,可将GPCR cDNA克隆到腺病毒双分子荧光互补(BiFC)载体中,并在重组腺病毒转导的细胞中进行b-arrestin BiFC分析。用基于腺病毒的b-arrestin BiFC测定法对生长抑素受体2(SSTR2)的激活进行的分析表明,该测定法适用于定量响应特定激动剂或拮抗剂的SSTR2激活。此外,基于腺病毒的b-arrestin BiFC测定法能够检测多种GPCR的激活。总体而言,我们的数据表明,基于腺病毒的b-arrestin BiFC测定法可作为研究GPCR激活的简单通用平台,因此可用于高通量筛选靶向GPCR的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号